Navigation Links
ISPE Conference to Benchmark and Advance Quality by Design in the Biopharmaceutical Industry
Date:3/7/2013

TAMPA, Fla., March 7, 2013 /PRNewswire/ -- ISPE announced today that it will hold its first-ever conference focused on benchmarking and advancing the development of Quality by Design (QbD) in the biopharmaceutical industry. The two-day event, taking place 10 – 11 April 2013 in San Francisco, Calif. USA, will feature workshops and discussions on the industry's progress since the introduction of A-Mab and steps for further adoption of QbD principles. The conference is endorsed by CASSS, a not-for-profit 501(c)(6) professional scientific society made up of over 4,000 industry, academic and public sector professionals.

"Quality by Design is a critical issue for the industry, with companies and global regulatory authorities working to help the industry adopt QbD practices," said Nancy Berg , ISPE President and CEO. "As the global pharmaceutical association representing the entire pharmaceutical lifecycle, ISPE will bring together top QbD experts to discuss how planning and controlling product evolution can lead to superior quality, better resource use and increased business effectiveness."

The State of Quality by Design in the Biopharmaceutical Industry Conference will offer in-depth case studies, lessons learned and best practices in implementing QbD. Pfizer's Roger Nosal , Vice President, Global Chemistry, Manufacturing and Controls (GCMC), will present a plenary address titled "Carpe Opportunite: Regulatory Experience with Implementation of QbD, An Industry Perspective." Mr. Nosal has an extensive history of leading advanced technology dialog among industry and regulators.

Speakers and delegates from Abbott, Amgen, Eli Lilly, Genentech, MedImmune, Merck, Pfizer, Roche and more will explore challenges and solutions with industry and regulatory experts and peers in workshops on design space, control strategies, successful dossiers and lifecycle management. The content of these workshops will be infused with attendees' pre-conference input, resulting in discussions specifically tailored to audience concerns. After the event, aggregate workshop results will be compiled and re-structured to produce a set of proposed QbD solutions that will be carried forward to US and European health authorities.

More information on The State of Quality by Design in the Biopharmaceutical Industry Conference, including complete education details and registration information, is available at www.ISPE.org/2013QbDConference.

About ISPE
ISPE, the International Society for Pharmaceutical Engineering, is the world's largest not-for-profit association serving its Members through leading scientific, technical and regulatory advancement throughout the pharmaceutical lifecycle. The 20,000 Members of ISPE are building solutions in the development and manufacture of safe and effective pharmaceutical and biologic medicines and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Tampa, Florida, USA and offices in Brussels, Belgium, Singapore and Shanghai, China. Visit www.ISPE.org for more information.

For more information contact:
Danielle Hould
ISPE Communications Manager
Tel: +1-813-960-2105, ext. 277
email: dhould@ispe.org
www.ISPE.org  


'/>"/>
SOURCE ISPE
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Palatin Technologies, Inc. to Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
2. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
3. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
4. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
5. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
6. Masimo to Present at 23rd Annual Piper Jaffray Health Care Conference
7. Sequenom Announces Participation at the 23rd Annual Piper Jaffray Healthcare Conference
8. PRA Expert to Present at Pharmacovigilance Conference
9. SuperNova Diagnostics® to Present at the 23rd Annual Piper Jaffray Healthcare Conference in New York City
10. Verenium to Present at Baird Clean Technology Conference
11. Senesco Technologies, Inc. to Webcast, Live, at RetailInvestorConferences.com on December 1st
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... on what they believe could be a new and helpful biomarker for malignant ... Click here to read it now. , Biomarkers are components in ...
(Date:6/27/2016)... 2016  Liquid Biotech USA ... a Sponsored Research Agreement with The University of ... from cancer patients.  The funding will be used ... with clinical outcomes in cancer patients undergoing a ... be employed to support the design of a ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of ... the Cary 5000 and the 6000i models are higher end machines that use the ... of the spectrophotometer’s light beam from the bottom of the cuvette holder. , ...
(Date:6/23/2016)...   Boston Biomedical , an industry leader ... target cancer stemness pathways, announced that its lead ... Designation from the U.S. Food and Drug Administration ... gastroesophageal junction (GEJ) cancer. Napabucasin is an orally ... stemness pathways by targeting STAT3, and is currently ...
Breaking Biology Technology:
(Date:6/2/2016)... 2, 2016   The Weather Company , an IBM ... an industry-first capability in which consumers will be able to ... ask questions via voice or text and receive relevant information ... Marketers have long sought an advertising solution that ... be personal, relevant and valuable; and can scale across millions ...
(Date:6/1/2016)... 1, 2016 Favorable Government Initiatives ... and Criminal Identification to Boost Global Biometrics System Market ... TechSci Research report, " Global Biometrics Market By ... and Opportunities, 2011 - 2021", the global biometrics market ... on account of growing security concerns across various end ...
(Date:5/20/2016)... -- VoiceIt is excited to announce its new marketing ... working together, VoiceIt and VoicePass will offer an ... slightly different approaches to voice biometrics, collaboration between ... Both companies ... "This marketing and technology partnership allows VoiceIt ...
Breaking Biology News(10 mins):